European Medicines Agency must take account of cardiovascular harm associated with degludec insulin

Thomas A. Schmidt, Clifford J. Rosen, John S. Yudkin

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

Adgang til dokumentet

@article{0e93e715590e4cb6bbbf84eda0e8d238,

title = "European Medicines Agency must take account of cardiovascular harm associated with degludec insulin",

author = "Schmidt, {Thomas A.} and Rosen, {Clifford J.} and Yudkin, {John S.}",

year = "2013",

month = jun,

day = "20",

doi = "10.1136/bmj.f3731",

language = "English",

volume = "346",

journal = "British Medical Journal",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7912",

}

TY - JOUR

T1 - European Medicines Agency must take account of cardiovascular harm associated with degludec insulin

AU - Schmidt, Thomas A.

AU - Rosen, Clifford J.

AU - Yudkin, John S.

PY - 2013/6/20

Y1 - 2013/6/20

UR - http://www.scopus.com/inward/record.url?scp=84879201353&partnerID=8YFLogxK

U2 - 10.1136/bmj.f3731

DO - 10.1136/bmj.f3731

M3 - Letter

C2 - 23757746

AN - SCOPUS:84879201353

VL - 346

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8146

IS - 7912

M1 - f3731

ER -